The Hippo pathway was discovered as a conserved tumour suppressor pathway restricting cell proliferation and apoptosis. However, the upstream signals that regulate the Hippo pathway in the context of organ size control and cancer prevention are largely unknown. Here, we report that glucose, the ubiquitous energy source used for ATP generation, regulates the Hippo pathway downstream effector YAP. We show that both the Hippo pathway and AMP-activated protein kinase (AMPK) were activated during glucose starvation, resulting in phosphorylation of YAP and contributing to its inactivation. We also identified glucose-transporter 3 (GLUT3) as a YAP-regulated gene involved in glucose metabolism. Together, these results demonstrate that glucose-mediated energy homeostasis is an upstream event involved in regulation of the Hippo pathway and, potentially, an oncogenic function of YAP in promoting glycolysis, thereby providing an exciting link between glucose metabolism and the Hippo pathway in tissue maintenance and cancer prevention.
The Hippo pathway was initially identified through genetic screening in Drosophila as having crucial roles in restricting tissue growth [1] [2] [3] . The evolutionarily conserved functions of this pathway in control of tissue and organ size were further demonstrated through genetically engineered mouse models. In mammalian systems, the Hippo pathway is composed of core kinase complexes (MST1/2 and LATS1/2), adaptor proteins (SAV1 for MST1/2 and MOB1 for LATS1/2), downstream effectors (YAP and TAZ) and nuclear transcription factors (TEAD1/2/3/4). MST1/2 kinase phosphorylates and activates LATS1/2 kinases. Active LATS1/2 phosphorylates YAP at Serine 127 (S127) and provides the docking site for the 14-3-3 protein, which sequesters YAP in cytoplasm. Moreover, LATS1/2 phosphorylates YAP at S381, which leads to YAP degradation through the β-TRCP E3 ligase complex 4 . Un-phosphorylated YAP translocates into the nucleus and functions as a transcriptional co-activator by binding to the TEAD family of transcription factors. The YAP-TEAD complex regulates transcription of genes that promote proliferation and inhibit apoptosis, two key events for organ size control. Nuclear protein VGLL4 directly competes with YAP for binding to TEAD transcription factors and consequently inhibits YAP's transcriptional functions 5, 6 . Notably, ablation of Hippo pathway components leads to tumour formation [7] [8] [9] , which suggested that the Hippo pathway is a tumour suppressor pathway. As the major target of the Hippo pathway, YAP has been identified as an oncogene. Transgenic expression of YAP in mouse liver reversibly enlarged livers and eventually led to tumour formation 10, 11 . Moreover, downregulation of Hippo pathway components and elevated activation of YAP/TAZ have been observed in various human cancers 11, 12 , which further demonstrates the critical roles of the Hippo pathway in human cancer prevention.
Many studies in recent years have been devoted to identification of upstream regulators of the Hippo pathway to elucidate the mechanisms underlying organ size control. These studies uncovered many components of the cell adhesion junction and tight junction as Hippo pathway regulators, findings that agree with the known celldensity-dependent regulation of the Hippo pathway 13 . Cytoskeletonmediated mechanical force also plays a key role in YAP regulation [14] [15] [16] . Moreover, G-protein-coupled receptors function upstream of the Hippo pathway through Rho GTPase and cytoskeleton remodelling 17 . However, the upstream signals that regulate the Hippo pathway in the context of organ size control and cancer prevention are still largely unknown.
In this study, we identified crosstalk between glucose metabolism and the Hippo pathway. The energy stress generated by a defect in glucose metabolism activated LATS kinase and AMPK kinase, leading to phosphorylation of YAP and inhibition of its cellular functions. On the other hand, YAP promoted glucose metabolism through upregulation of glucose-transporter 3 (GLUT3) expression at the transcriptional level. These findings revealed a critical crosstalk between energy homeostasis and the Hippo pathway, underlining metabolic control of the Hippo pathway and a previously unknown function of the Hippo pathway in glucose metabolism.
RESULTS

Glucose homeostasis regulates YAP phosphorylation and localization
We explored whether any growth condition might control activation of the Hippo pathway and found that glucose starvation increased phosphorylation of YAP at S127 (Fig. 1a) , the major phosphorylation site regulated by the Hippo pathway. When glucose was added back to glucose-deprived cells, the phosphorylation of YAP at S127 markedly decreased (Fig. 1a) . This glucose-stimulated effect was transient, because the phosphorylation of YAP gradually recovered after 2 h or longer (Fig. 1a) . The levels of YAP upstream kinases LATS1 and MST1 were not affected by glucose (Fig. 1a) , whereas this glucose switch, as expected, regulated phosphorylation of ACC and activation of S6K, AKT and ERK (Fig. 1a) .
To further validate these findings, glucose-starved cells were given different types of glucose-containing medium: regular glucose-rich medium (25 mM glucose), or glucose-free medium containing either D-glucose (25 mM) or 2-deoxy-D-glucose (2-DG, 25 mM). 2-DG is a glucose molecule that has the 2-hydroxyl group replaced by hydrogen, so that it fails to undergo further glycolysis and therefore leads to energy stress due to reduced ATP production. The phosphorylation of YAP decreased in cells stimulated by the regular glucose-rich medium or the D-glucose-containing medium, but not in cells stimulated by 2-DG-containing medium (Fig. 1b) . The subcellular localization of YAP corresponded to its phosphorylation status: YAP localized mostly in cytoplasm in glucose-starved cells (Fig. 1c) , and whereas glucose-rich medium and D-glucose-containing medium induced nuclear translocation of YAP, YAP was retained in the cytoplasm in cells cultured with 2-DG-containing medium (Fig. 1c) . These data suggest that glucose status regulates YAP phosphorylation and subcellular localization.
To determine the role of 2-DG in YAP regulation, cells were treated transiently with glucose starvation, 2-DG or a combination. The combination increased YAP phosphorylation to a greater extent than 2-DG treatment alone (Fig. 1d) . Moreover, the effect of 2-DG treatment on YAP was dose dependent (Fig. 1e) . These data indicate that a 2-DG-induced defect in glucose metabolism could inhibit YAP function.
Release of energy stress activates YAP
Glucose is widely used as an energy source in various organisms, and defects in glucose metabolism create energy stress in the cell 18, 19 . To further address the role of energy stress in YAP function, we employed YAP-regulated gene transcripts (CTGF, CYR61 and ANKRD1) were detected by quantitative PCR in cells under energy stress or released from energy stress for 2 h and normalized (mean ± s.d., n = 3 biological replicates). * P < 0.05, * * P < 0.01 and * * * P < 0.001 (Student t-test). (e) YAP phosphorylation was higher in livers of fasting mice than in livers of mice fed after fasting. Mice that had fasted for 16 h were then fed (n = 3) or fasted (n = 3) for another 5 h. Livers were collected and subjected to lysis and western blotting. The arrow indicates increasing YAP phosphorylation. (f) YAP translocated into the nucleus in the liver of a fasting mouse after feeding. A liver from a fasting mouse and a liver from a mouse fed after fasting from e were randomly chosen for immunohistochemical staining with YAP antibody, followed by haematoxylin staining to visualize the nucleus. Scale bar, 30 µm. The boxed region is enlarged below. (g) YAP transcriptional activity increased in fasting mouse liver after feeding. Transcription of YAP-regulated genes (Ctgf, Cyr61, Acta2 and Amotl2) was detected by quantitative PCR in livers randomly chosen from mice in e (mean ± s.d., n = 3 biological replicates). * P < 0.05 and * * P < 0.01 (Student t-test). Statistics source data are shown in Supplementary Table 2 . Uncropped images of western blots are shown in Supplementary Fig. 7 .
three different methods to induce energy stress in cells: glucose starvation, treatment with 2-DG, and treatment with 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR). AICAR is phosphorylated by adenosine kinase to form ZMP, an analogue of AMP, thereby mimicking energy stress conditions with a high AMP level. Under all three of these conditions, YAP localized mostly in the cytoplasm in both HEK293A and MCF10A cells (Fig. 2a) . Notably, however, YAP translocated into the nucleus when cells were released from energy stress (Fig. 2a) . The decrease of YAP phosphorylation on release from energy stress was observed by both western blotting with YAP phospho-specific antibody (S127) and the migration shift of YAP in phospho-tag gel (Fig. 2b) . Consistent with these findings were the observations that release from energy stress diminished YAP's association with the 14-3-3 protein, while increasing its interaction with TEAD1 (Fig. 2c) . Accordingly, release from energy stress also increased the transcription of YAP downstream target genes CTGF, CYR61 and ANKRD1 (Fig. 2d) , indicating that release from energy stress activates YAP. We also investigated YAP activity in liver samples obtained from mice that had fasted for 16 h and then were fed or fasted for another 5 h. YAP was less phosphorylated in the liver samples from fed mice than in those from fasting mice (Fig. 2e) . Moreover, in the livers of fed mice, YAP translocated into nucleus ( Fig. 2f ) and promoted transcription of its downstream target genes (Fig. 2g) . These results indicate the physiological relevance of energy homeostasis in the regulation of YAP activity.
AMPK associates with and phosphorylates YAP
To identify the mechanisms underlying the regulation of YAP by energy stress, we isolated YAP-associated protein complexes in glucose-starved HEK293A cells through tandem affinity purification followed by mass spectrometry analysis. Surprisingly, the AMPK α and γ subunits were identified on the prey list (Fig. 3a) . The specific interaction between AMPK and YAP was confirmed by pulldown assays (Fig. 3b,c) . Co-expression of YAP with an AMPKα1 C-terminal-truncated mutant (amino acids 1-312), which has been demonstrated to be a constitutively active form of AMPK (refs 20,21) , but not with its inactive counterpart (T172A), induced YAP migration shift in phospho-tag gel (Fig. 3d) , suggesting that YAP is phosphorylated by AMPK in vivo. Since AMPK is a master regulator of energy homeostasis and is activated by energy stress, our results indicate that AMPK may directly phosphorylate YAP in response to energy stress.
AMPK phosphorylates YAP on several residues including the S61 site
In searching for AMPK phosphorylation sites on YAP, we again used mobility shift in phospho-tag gel to assess YAP phosphorylation. We found that the YAP-5SA mutant 13 could not be phosphorylated as markedly as wild-type YAP by the active AMPK truncation mutant ( Fig. 4a) , which indicated that one or more of these mutated serine residues is the AMPK phosphorylation site(s). The YAP-5SA mutant was originally generated to mutate all of the putative LATS kinase phosphorylation sites on YAP (refs 4,13,22) . We sequenced this mutant and confirmed that it comprises eight serine sites mutated to alanine (Fig. 4b) . Mutation of each alanine back to serine generated six different YAP-4SA mutants, and of these only YAP-4SA-61S could be intensely phosphorylated by AMPK as evaluated by phosphotag gel analysis (Fig. 4c) . The YAP-S61A mutant could not be strongly phosphorylated by AMPK in the same experiments (Fig. 4d) , indicating that the YAP S61 site is an AMPK phosphorylation site.
We also performed in vitro kinase assays and analysed YAP phosphorylation site(s) by mass spectrometry as an independent method to identify AMPK phosphorylation sites. We again uncovered S61, as well as two other sites (S94 and T119), as AMPK phosphorylation sites (Supplementary Fig. 1 and Supplementary Table 1 ), suggesting that AMPK may phosphorylate S61 as well as other sites on YAP. These data agree with the observation that energy stress was capable of inducing a mild shift of the YAP-5SA mutant in phospho-tag gel (Supplementary Fig. 2A ). To further confirm that S61 is an AMPK phosphorylation site, we generated YAP S61 phospho-specific antibody and validated its specificity in vitro and in vivo ( Supplementary Fig. 2B-D) . Using this antibody, we showed that YAP S61 phosphorylation increased following 2-DG treatment in wild-type mouse embryonic fibroblasts (MEFs) but not in AMPKα-knockout MEFs (Fig. 4e) , suggesting that AMPK phosphorylates YAP at the S61 site in response to energy stress. Notably, the S61 site is evolutionarily conserved (but not in Drosophila) and shows some similarity to the consensus AMPK phosphorylation site ( Supplementary Fig. 2E ).
AMPK phosphorylates YAP in parallel with the Hippo pathway
Although YAP S127 phosphorylation increased following energy stress ( Fig. 1) , AMPK did not seem to be the major contributor to the phosphorylation of YAP at the S127 site (Fig. 4f) . LATS1 phosphorylation and MST1 phosphorylation were not significantly affected by the active AMPK truncation mutant ( Supplementary  Fig. 3A,B) . Moreover, LATS1 kinase activation induced by 2-DG treatment was not markedly different in wild-type or AMPK-knockout MEFs ( Fig. 4g and Supplementary Fig. 3C ). These results indicate that energy stress activates the Hippo pathway in a manner that is largely independent of AMPK. The S61 site was previously predicted to be a LATS phosphorylation site 4, 13, 22 . However, the Hippo core kinase complex could phosphorylate only the YAP-4SA-127S mutant but not the YAP-4SA-61S mutant (Fig. 4h) . These results indicate that energy stress may activate two parallel cellular signalling pathways, AMPK and the Hippo pathway, which phosphorylate YAP at least at the S61 and S127 sites, respectively.
AMPK-mediated YAP phosphorylation inhibits YAP transcriptional activity
Previous studies suggested that phosphorylation of YAP increased its interaction with the 14-3-3 protein, which sequesters YAP in the cytoplasm 11, 13, 22 . The 5SA mutant of YAP blocked YAP's association with the 14-3-3 protein, translocated YAP into the nucleus and increased YAP transcriptional functions 11, 13, 22 . Since the YAP S61 site is among the putative phosphorylation sites mutated in the 5SA mutant, we first examined whether AMPK would affect the interaction between YAP and the 14-3-3 protein. AMPK-mediated YAP phosphorylation did not increase the association of YAP with 14-3-3 ( Supplementary Fig. 4A ). The S127 site, but not the S61 site, was the binding site for the 14-3-3 protein ( Supplementary  Fig. 4B,C) . The active AMPK truncation mutant did not change YAP localization ( Supplementary Fig. 4D ), and the YAP S61 mutant did not regulate YAP nuclear localization (Supplementary Fig. 4E ). However, we noticed that the S61A single mutation increased the transcription of YAP downstream target genes (CTGF and CYR61; Fig. 4i ). These data suggest that YAP transcriptional activity was suppressed by S61 phosphorylation, although the binding between YAP and TEAD was ALDOC  BPGM  ENO1  ENO2  ENO3  GLUT1  GLUT2  GLUT3  GLUT4  GLUT10  GLUT12  GALM  GCK  GPI  GCKR  HK2  HK3  KHK  PFKL  PDK1  PDK2  PDK3  PDK4  PDP2  PDPR  PGM1  PGM2  PGM3  PGK1  PGK2  PGAM2 not noticeably affected by the phospho-mimetic mutant of the S61 site (S61D) (Supplementary Fig. 4F ). Exactly how AMPK-dependent S61 phosphorylation inhibits YAP transcriptional activity remains unknown. It is possible that this AMPK-dependent phosphorylation at the YAP S61 site may affect the binding of YAP with some yet unknown proteins required for YAP activity, and we are now investigating this hypothesis. On the other hand, the YAP S94 site was also identified as an AMPK phosphorylation site ( Supplementary Fig. 1 and Supplementary Table 1 ), and the phospho-mimetic mutant of this site (S94D) greatly diminished YAP-TEAD interaction (Supplementary Fig. 4F ). Moreover, a single phospho-mimetic mutation of either S61 or S94 suppressed YAP transcriptional activity, and the combined phosphomimetic mutation of both sites further suppressed it ( Supplementary  Fig. 4G ). These data indicate that AMPK may inhibit YAP transcriptional activities by phosphorylating multiple sites on YAP.
To further confirm the suppressive role of AMPK in YAP regulation, we examined YAP transcriptional activity in wild-type or AMPK-deficient MEFs. The transcription of YAP downstream genes was elevated in AMPK-knockout MEFs (Fig. 4j) . Moreover, loss of AMPK attenuated the relative suppressive effect on YAP induced by 2-DG compared with that in control MEFs (Fig. 4k) . Together, these results indicate that AMPK is a negative regulator of YAP in response to energy stress.
Energy stress activates LATS kinase but not MST kinase in the Hippo pathway
The observation that energy-stress-regulated YAP S127 phosphorylation ( Fig. 1) indicates that the Hippo pathway was also activated by energy stress. Interestingly, 2-DG treatment increased LATS1 kinase phosphorylation (T1079) (Fig. 5a) but not MST1 kinase phosphorylation (T183) (Fig. 5b) . Release from energy stress rapidly decreased the LATS1 phosphorylation but not MST1 phosphorylation (Fig. 5c) . Moreover, YAP S127 phosphorylation was increased by 2-DG in MST1/2 double-knockout cells (Fig. 5d) . These data indicate that energy stress induces YAP S127 phosphorylation through activation of LATS kinases but not MST kinases in the Hippo pathway.
Energy stress induces LATS kinase activation mainly through Rho GTPase and cytoskeleton
Previous studies suggested that Rho GTPase-mediated remoulding of actin cytoskeleton could inhibit LATS kinase and activate YAP independent of MST kinase 14, 17 . We therefore examined the roles of actin cytoskeleton and Rho GTPase in energy-stress-regulated YAP phosphorylation. In cells released from energy stress, latrunculin Bmediated actin depolymerization reversed the decrease of YAP S127 phosphorylation (Fig. 5e) . Rho GTPase inhibitor C3 also rescued the decrease of YAP S127 phosphorylation (Fig. 5e) . Furthermore, release from energy stress increased the Rho GTPase activity (GTP-formed Rho; Fig. 5f ). Although detailed mechanisms are still unclear, several studies have shown that the activity of Rho GTPase is regulated by glucose treatment [23] [24] [25] , which is consistent with our findings presented in Fig. 5f . Thus, energy stress may activate LATS kinases by modulating Rho GTPase activity. It remains to be determined whether the actin cytoskeleton plays a direct and specific role in this process.
Active YAP promotes glycolysis
The results presented so far established a connection between glucose homeostasis and the regulation of YAP. The next question is the functional significance of this regulation. We noticed, interestingly, that the culture medium for YAP-5SA cells quickly turned yellow compared with the culture media for the vector-control cells, the wild-type YAP cells or the TEAD non-binding mutant YAP-S94A (ref. 26 ) cells (Fig. 6a) , although the numbers of cells in each culture were similar. The yellow colour of the medium indicated that it had been acidified and the level of glycolysis increased in these cells 27 . Indeed, the YAP-5SA medium showed a lower pH value but higher glucose uptake and lactate production than media from other cell lines (Fig. 6b-d) . These data suggest that YAP is involved in the glucose metabolism pathway and that this involvement is probably mediated by its target genes.
YAP upregulates GLUT3 in glucose metabolism pathway
To identify YAP-regulated genes involved in glucose metabolism, we examined the transcription of a panel of glucose metabolism-related genes in cells expressing the YAP-5SA mutant and in vector-control cells. The analysis showed that GLUT3 transcription was much higher in YAP-5SA cells than in vector-control cells (Fig. 6e) . The dependence on YAP transcriptional activity was confirmed in YAP-5SA-S94A cells, in which GLUT3 transcription decreased (Fig. 6f) . Similar findings were obtained from other cell lines (Fig. 6g,h ). Furthermore, a higher level of GLUT3 protein was detected in YAP-5SA cells than in other cells by western blotting (Fig. 6i,j) . Downregulation of YAP (Fig. 6k) suppressed the increase of GLUT3 transcription in cells released from energy stress (Fig. 6l) . We identified a conserved TEAD-binding site in the GLUT3 promoter, and ENCODE data showed that this site was bound by TEAD ( Supplementary Fig. 5 ). These results indicate that YAP-TEAD may directly regulate the transcription of GLUT3. Moreover, results from two other studies 26, 28 suggested that the expression of GLUT3 was upregulated by active YAP, which support our findings that YAP regulates GLUT3 expression.
To determine the role of GLUT3 in YAP-mediated glycolysis, we knocked down GLUT3 in YAP-5SA cells (Fig. 6m) and found that this downregulation of GLUT3 partially reversed medium acidification, glucose uptake and lactate production in cells expressing the YAP-5SA mutant (Fig. 6n-q) . These data suggest that GLUT3 is at least one of the downstream effectors involved in YAP-regulated glycolysis.
GLUT3 expression correlates with YAP protein level in human liver and colon cancers
Since high expression of GLUT3 has been identified in various types of cancers [29] [30] [31] [32] [33] [34] , we examined expression of YAP and GLUT3 in samples of human cancer, specifically colon and liver cancers. Indeed, the expression of YAP and GLUT3 was higher in tumour samples than in normal tissues (Fig. 7a) , and their expressions were positively correlated in tumour samples (Fig. 7b) . These data indicate a potential role for YAP in regulating GLUT3 expression in human cancers.
DISCUSSION
In this study, we unexpectedly discovered that AMPK, the master kinase that senses the cellular AMP/ATP ratio, directly phosphorylates YAP and inhibits YAP transcriptional activity. We demonstrated that AMPK directly phosphorylates YAP at multiple sites and thus suppresses YAP transcriptional activity. We primarily investigated phosphorylation at S61 by AMPK, as this phosphorylation is the major event contributing to YAP migration shift on phospho-tag gel. We also noticed a minor shift of the YAP-5SA mutant on phospho-tag gel, indicating that there are additional phosphorylation sites. Indeed, our mass spectrometry analysis supports these findings and revealed two more AMPK phosphorylation sites on YAP, S94 and T119. The estimated phosphorylation on these three sites indicated that S61 (11.27%) and S94 (2.39%) are relatively dominant phosphorylation sites compared with T119 (0.53%). The S94 site is known to be required for YAP's binding to TEAD and mutation of this site (S94A) abolishes TEAD-dependent YAP transcriptional activity 26 . The phospho-mimetic mutant of S94 (S94D) also inhibited the interaction between YAP and TEAD as well as transcription of YAP downstream target genes. In this issue, Guan and colleagues report similar findings about AMPK-dependent YAP phosphorylation on the S94 site, complementing our results 35 . Together, with their findings, our results suggest that AMPK may phosphorylate multiple sites on YAP and inhibit YAP transcriptional activity.
We also revealed that energy stress increases S127 phosphorylation and cytoplasmic localization of YAP by activating the Hippo pathway. We explored the crosstalk between AMPK and the Hippo pathway, because both pathways are activated following energy stress. In LATSor MST-deficient cells, AMPK activity, as indicated by ACC S79 phosphorylation, was still increased by 2-DG treatment (Fig. 5d) , suggesting that AMPK is activated by energy stress independent of the Hippo pathway. On the other hand, 2-DG-induced LATS kinase activation was slightly decreased in AMPKα-knockout MEF cells ( Fig. 4g and Supplementary Fig. 3C ), indicating the involvement of both AMPK-dependent and -independent pathways in the regulation of LATS kinase activity in response to energy stress. The AMPKdependent regulation of the Hippo pathway is in agreement with recent finding that AMPK may activate the Hippo pathway by increasing the levels of angiomotin family proteins under energy stress 36 . Our findings showed that the AMPK-independent pathway may be regulated by Rho GTPase, although the detailed mechanisms remain to be elucidated. Similar findings are reported by Guan and colleagues in this issue 35 . Therefore, both AMPK and the Hippo pathway are activated following energy stress, which act together to suppress YAP activity (Supplementary Fig. 6 ).
Our results demonstrated that the Hippo pathway is intimately associated with glucose homeostasis. This is highly significant as it establishes a connection between a pathway involved in organ size control and nutrient availability. The discovery of AMPK as a kinase for YAP, reported here, extends our understanding of YAP regulation outside of the classic Hippo pathway. The identification of GLUT3 as a YAP-regulated gene offers a potential link between the Hippo pathway and cancer metabolism. As hallmarks of cancer 19 , tumour cells are known to reprogram their signalling pathways and metabolism to support their uncontrolled proliferation and survival. Our study proposes yet another oncogenic function of YAP, via promotion of glucose uptake and glycolysis, which warrants further investigation.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3113 METHODS Antibodies. Anti-YAP antibody (1:1,000 dilution) was raised by immunizing rabbits with bacterially expressed and purified GST-fused human full-length YAP protein. Anti-AMOTL2 antibody (1:1,000 dilution) was raised by immunizing rabbits with bacterially expressed and purified GST-fused human AMOTL2 (amino acids 1∼675). Antisera were affinity purified by using the AminoLink Plus immobilization and purification kit (Pierce). Anti-YAP S61 phospho-specific antibody (1:1,000 dilution) was raised against keyhole limpet haemocyaninconjugated phospho-peptide Biotin-QIVHVRGD(phospho-S)ETDLEALC, and antiserum was affinity purified through SulfoLink peptide coupling gel. Additional anti-YAP (sc101199, 1:200 dilution for immunostaining) and anti-phospho-YAP (S127) (4911S, 1:1,000 dilution) antibodies were purchased from Santa Cruz Biotechnology and Cell Signaling Technology respectively. Anti-α-tubulin (T6199-200UL, 1:5,000 dilution) and anti-flag (M2) (F3165-5MG, 1:5,000 dilution) monoclonal antibodies were obtained from Sigma-Aldrich. Anti-Myc (sc-40, 1:1,000 dilution), anti-GST (sc-138, 1:1,000 dilution) and anti-14-3-3θ (sc-732, 1:1,000 dilution) monoclonal antibodies were purchased from Santa Cruz Biotechnology. Anti-TEAD1 (610922, 1:1,000 dilution) monoclonal antibody was obtained from Millipore. Anti-phospho-AKT1 (Ser473) (9271S, 1:1,000 dilution), anti-phospho-ERK1/2 (Thr202/Tyr204) (9100S, 1:1,000 dilution), anti-phospho-ACC (Ser79) (3661S, 1:1,000 dilution), anti-ACC (3662S, 1:1,000 dilution), anti-phospho-p70 S6K (Thr389) (9205S, 1:1,000 dilution), anti-phospho-AMPKα (Thr172) (2531S, 1:1,000 dilution), anti-AMPKα ( 2532S, 1:1,000 dilution ), anti-phospho-LATS1 (Thr1079) (8654S, 1:1,000 dilution), anti-LATS1 (9153S, 1:1,000 dilution and 3477S, 1:100 dilution for immunoprecipitation), anti-phospho-MST1 (Thr183)/MST2 (Ser180) (3681S, 1:1,000 dilution) and anti-MST1 (3682S, 1:1,000 dilution) polyclonal antibodies were purchased from Cell Signaling Technology. Anti-GLUT3 (sc-30107, 1:1,000 dilution) polyclonal antibody was purchased from Santa Cruz Biotechnology. Anti-RhoA (ARH03-A, 1:1,000 dilution) monoclonal antibody and GST-Rhotekin-RBD protein (RT01-A) were obtained from Cytoskeleton.
Constructs and viruses.
All constructs were generated by polymerase chain reaction (PCR) and subcloned into pDONOR21 vector using GatewayTechnology (Invitrogen) as the entry clones. As needed, the entry clones were subsequently recombined into gateway-compatible destination vectors for the expression of Nor C-terminal-tagged fusion proteins. pEBG-AMPKα1 (amino acids 1-312) was purchased from Addgene (plasmid no 27632). pCMV-Flag YAP2 5SA (plasmid no 27371), HA-MST2 (plasmid no 33098), HA-SAV1 (plasmid no 32834) and HA-MOB1 (plasmid no 32835) were all obtained from Addgene. PCR-mediated sitedirected mutagenesis was used to generate serial point mutations as indicated. The GST-ACC (amino acids 1∼130) construct was kindly provided by Z. Luo (Boston University, USA).
HA-Flag-tagged retroviruses for various YAP mutants were generated by cotransfecting with pCL-Ampho packaging vector in the BOSC23 cell line. Cells were infected twice by 0.45-µm-filtered retrovirus with the addition of Polybrene (8 µg ml −1 ) and selected with puromycin (2 µg ml −1 ). Pooled stable cells were used for all the experiments after validation by immunostaining and western blotting.
The SFB-YAP lentiviral expression vector was generated by inserting the gateway response fragment (attR1-ccdB-attR2)-fused SFB tag into the XbaI and SwaI multi-clonal sites of the pCDH-CMV-EF1-GFP vector (kindly provided by M. J. You, MD Anderson Cancer Center, USA). YAP was cloned into this vector through a gateway-based LR reaction. YAP shRNA1 (plasmid no 27368) and shRNA2 (plasmid no 27369) were obtained from Addgene. GLUT3 shRNAs (TRCN0000043615 and TRCN0000042880) were purchased from Open Biosystems. All lentiviral supernatants were generated by transient transfection of 293T cells with helper plasmids pSPAX2 and pMD2G (kindly provided by Z. Songyang, Baylor College of Medicine, USA) and harvested 48 h after transfection. Supernatants were passed through the 0.45 µm filter and used to infect cells with the addition of Polybrene (8 µg ml −1 ).
Cell culture and transfection. HEK293T and HeLa cells were purchased from American Type Culture Collection (ATCC) and maintained in Dulbecco modified essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37 • C in 5% CO 2 (v/v). HEK293A cells were kindly provided by J-I. Park (MD Anderson Cancer Center, USA). MCF10A cells, purchased from ATCC, were kindly provided by D. Yu (MD Anderson Cancer Center, USA). MCF10A cells were maintained in DMEM/F12 medium supplemented with 5% horse serum, 200 ng ml −1 epidermal growth factor, 500 ng ml −1 hydrocortisone, 100 ng ml −1 cholera toxin and 10 µg ml −1 insulin at 37 • C in 5% CO 2 (v/v). SUM159 cells, purchased from ATCC, were kindly provided by L. Ma (MD Anderson Cancer Center, USA) and maintained in F12 medium containing 5% FBS, insulin (5 µg ml −1 ), hydrocortisone (1 µg ml −1 ) and HEPES (10 mM). The MDA-MB-231 cells, purchased from ATCC, were kindly provided by M-C. Hung (MD Anderson Cancer Center, USA) and cultured in DMEM with 10% FBS. AMPKα-knockout MEFs and wild-type MEFs were kindly provided by B. Viollet (University Paris Descartes, Institut Cochin, France) and cultured in DMEM with 10% FBS. All culture media contained 1% penicillin and streptomycin antibiotics. Plasmid transfection was performed with the polyethylenimine reagent.
Tandem affinity purification of SFB-tagged protein complexes. HEK293A cells were infected twice with SFB-YAP lentivirus. Pooled cells stably expressing the tagged YAP were selected by culturing in medium containing puromycin (2 µg ml −1 ), and the protein expression was confirmed by immunostaining and western blotting. Cells were washed once and cultured in glucose-free DMEM (Invitrogen) with 10% dialysed FBS (Gemini Bio-Products) for 18 h.
For affinity purification, glucose-starved HEK293A cells were subjected to lysis in NETN buffer (100 mM NaCl, 20 mM Tris-Cl, 0.5 mM EDTA, 0.5% Nonidet P-40) with protease and phosphatase inhibitors at 4 • C for 20 min. Crude lysates were subjected to centrifugation (14,000 r.p.m.) at 4 • C for 15 min. Supernatants were incubated with streptavidin-conjugated beads (Amersham) for 4 h at 4 • C. The beads were washed three times with NETN buffer, and bound proteins were eluted with NETN buffer containing biotin (2 mg ml −1 ; Sigma) overnight at 4 • C. The elutes were incubated with S protein beads (Novagen) for 4 h. The beads were washed three times with NETN buffer and subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). Protein bands were excised and subjected to mass spectrometry analysis (performed by the Taplin Mass Spectrometry Facility, Harvard Medical School).
Mouse fasting experiment. Five-week old C57/B6 female mice were randomly assigned to fasting and fasting-feed groups. The animal experiments were performed in accordance with a protocol approved by the Institutional Animal Care and Use Committee (IACUC) of MD Anderson Cancer Center. Mice that had fasted for 16 h were then fed (n = 3) or fasted (n = 3) for another 5 h. Livers from these animals were collected and subjected to the indicated experiments.
Immunofluorescent staining. Cells cultured on coverslips were fixed by 4% paraformaldehyde for 10 min at room temperature and then extracted with 0.5% Triton X-100 solution for 5 min. After blocking with Tris-buffered saline and Tween 20 solution containing 1% bovine serum albumin, cells were incubated with the indicated primary antibodies for 1 h at room temperature. After that, cells were washed and incubated with fluorescein isothiocyanate or rhodamineconjugated second primary antibodies (1:3,000 dilution, Jackson ImmunoResearch) for 1 h. Cells were counterstained with 100 ng ml −1 4 ,6-diamidino-2-phenylindole (DAPI) for 2 min to visualize nuclear DNA. The cover slips were mounted onto glass slides with anti-fade solution and visualized on a Nikon ECLIPSE E800 fluorescence microscope with a Nikon Plan Fluor ×60 oil objective lens (NA 1.30).
RNA extraction, reverse transcription and real-time PCR. RNA samples were extracted with TRIZOL reagent (Invitrogen). Reverse transcription assay was performed by using the ProtoScript M-MuLV Taq RT-PCR Kit (New England Biolabs) according to the manufacturer's instructions. Real-time PCR was performed by using Power SYBR Green PCR master mix (Applied Biosystems). For quantification of gene expression, the 2 − Ct method was used. GAPDH expression was used for normalization. The sequence information for each primer used for gene expression analysis is as follows:
For Glucose uptake assay. Cells were seeded in 10-cm dishes. Twenty-four hours later, cells were washed and refreshed with glucose-free DMEM with 10% dialysed FBS. Eighteen hours later, cells were treated with 2-NBDG (50 µM; Invitrogen) for 1 h and washed with ice-cold phosphate-buffered saline solution twice. Glucose uptake was quantified in the propidium iodide-negative population of cells using fluorescenceactivated cell sorting analysis.
Lactate production assay. Cells were seeded in 6-cm dishes. Forty-eight hours later, cell medium was removed and lactate concentration was determined by using Lactate Plus test strips and a Lactate Plus meter (Nova Biomedical). The cells remaining in the dish were harvested and counted by using a haemocytometer on a microscope. The rate of lactate production was calculated (lactate production = total lactate mole number/cell number).
Immunohistochemical analysis. Colon and liver tissue arrays were purchased from US Biomax. Samples were deparaffinized and rehydrated, and antigens were retrieved by applying Unmask Solution (Vector Laboratories) in a steamer for 30 min. To block endogenous peroxidase activity, the sections were treated with 1% hydrogen peroxide in methanol for 30 min. After 1 h pre-incubation in 10% goat serum to prevent nonspecific staining, the samples were incubated with an antibody to YAP (4912S, Cell Signaling Technology, 1:20 dilution) or GLUT3 (HPA006539, Sigma, 1:500 dilution) at 4 • C overnight. The sections were incubated with SignalStain Boost Detection Reagent for 30 min at room temperature. Colour was developed with the SignalStain DAB Chromogen diluted solution (all reagents were obtained from Cell Signaling Technology). Sections were counterstained with Mayer haematoxylin. The correlation between YAP and GLUT3 and the correlation of YAP or GLUT3 with tissue type (normal versus cancer) were determined by the chi-square test.
Statistical analysis. Each experiment was repeated twice or more, unless otherwise noted. No samples or animals were excluded from the analysis. For the mouse fasting experiment, no statistical method was used to predetermine sample size. The samples or animals were randomly assigned to different groups. A laboratory technician who provided animal care and collected the livers was blinded to the group allocation during all animal experiments and outcome assessment. Differences between groups were analysed by the Student t-test and Pearson chisquare analysis. A P value <0.05 was considered statistically significant. Phosphorylation analysis of YAP by liquid chromatography-mass spectrometry. Excised gel bands were cut into approximately 1 mm 3 pieces. The samples were reduced with 1 mM dithiothreitol for 30 min at 60 • C and then alkylated with 5 mM iodoacetamide for 15 min in the dark at room temperature. Gel pieces were then subjected to a modified in-gel trypsin digestion procedure 37 . Gel pieces were washed and dehydrated with acetonitrile for 10 min, after which acetonitrile was removed and gel pieces were completely dried in a SpeedVac. The gel pieces were rehydrated with 50 mM ammonium bicarbonate solution containing 12.5 ng µl −1 modified sequencing-grade trypsin (Promega) at 4 • C. Samples were then placed in a 37 • C room overnight. Peptides were later extracted by removing the ammonium bicarbonate solution, followed by one wash with a solution containing 50% acetonitrile and 1% formic acid. The extracts were then dried in a SpeedVac (∼1 h) and the samples were stored at 4 • C until analysis.
On the day of analysis the samples were reconstituted in 5 ∼ 10 µl of highperformance liquid chromatography solvent A (2.5% acetonitrile, 0.1% formic acid). A nano-scale reverse-phase HPLC capillary column was created by packing 2.6 µm C18 spherical silica beads into a fused silica capillary (100 µm inner diameter × ∼25 cm length) with a flame-drawn tip 38 . After the column was equilibrated, each sample was loaded via a Famos auto sampler (LC Packings) onto the column. A gradient was formed and peptides were eluted with increasing concentrations of solvent B (97.5% acetonitrile, 0.1% formic acid).
As each peptide was eluted, it was subjected to electrospray ionization and was then entered into an LTQ Orbitrap Velos Pro ion-trap mass spectrometer (Thermo Fisher Scientific). Eluted peptides were detected, isolated and fragmented to produce a tandem mass spectrum of specific fragment ions for each peptide. Peptide sequences (and hence protein identity) were determined by matching protein or translated nucleotide databases with the acquired fragmentation pattern with the software program Sequest (ThermoFinnigan) 39 . The modification of 79.9663 mass units to serine, threonine or tyrosine was included in the database searches to determine phospho-peptides. Phosphorylation assignments were determined by the Ascore algorithm 40 . Phospho-peptide with Ascore >13 was considered a putative phosphorylation site according to the instructions from the Taplin Mass Spectrometry Facility, Harvard Medical School.
In vitro kinase assay. Bacteria-purified GST proteins (GST, GST-YAP, GST-YAP-S61A and GST-ACC [amino acids 1∼130]) were subjected to dialysis against TrisHCl (pH 8.0; 20 mM) and 10% glycerol at 4 • C overnight. GST fusion proteins (2 µg) were used for the in vitro kinase assay in all the experiments. For the AMPK kinase assay, SFB-AMPKα1 or its kinase-dead mutant (K47R) was co-expressed with Flag-AMPKβ2 or Flag-AMPKγ2 plasmid in 293T cells for 48 h. AMPK complex was pulled down by S protein beads and subjected to the kinase assay in the presence of cold ATP (500 µM) and indicated GST fusion protein. The reaction mixture was incubated at 30 • C for 30 min, terminated with SDS loading buffer and subjected to SDS-PAGE and autoradiography. For the LATS kinase assay, endogenous LATS1 kinase was immunoprecipitated from the indicated cell lysates and the assay performed similarly. Phosphorylation of YAP at the S127 site was determined by YAP S127 phospho-antibody. 
